GO:0004725 protein tyrosine phosphatase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004725 protein tyrosine phosphatase activity describes the catalytic removal of a phosphate group from a phosphorylated tyrosine residue on a protein substrate.
• This activity is executed by a large superfamily of enzymes, including classical PTPs such as PTPN11 (SHP-2), receptor-like PTPs such as PTPRA, and non-receptor PTPs such as PTPN12 (PTP-PEST).
• Protein tyrosine phosphatases (PTPs) counterbalance protein tyrosine kinases and are essential for controlling signaling pathways that regulate immunity, metabolism, and cell growth.
• Dysregulated PTP activity is linked to cancer, metabolic disorders, and immune dysfunction, making these enzymes important drug targets.
• Fluorogenic sensors and structure-based virtual screening are key tools for measuring and inhibiting PTP activity in research and drug discovery.
• CRISPR-based knockout, point-mutation, and knock-in models enable precise functional dissection of individual PTPs in disease-relevant pathways.
Description
Protein tyrosine phosphatase activity (GO:0004725) is a fundamental enzymatic function that removes phosphate groups from tyrosine residues on proteins, directly opposing the action of protein tyrosine kinases. This activity is encoded by a diverse superfamily of enzymes that share a conserved catalytic mechanism but differ in substrate specificity, subcellular localization, and regulatory domains. Because tyrosine phosphorylation is a central switch in signal transduction, PTPs are critical for controlling processes as varied as immune cell activation, metabolic homeostasis, and angiogenesis. Researchers study GO:0004725 to understand how signaling pathways are turned off, how PTP mutations contribute to disease, and how these enzymes can be targeted therapeutically.
protein tyrosine phosphatase activity At A Glance
| GO ID | GO:0004725 |
|---|---|
| GO term | protein tyrosine phosphatase activity |
| Ontology | molecular_function |
| Synonym | PTPase activity; phosphotyrosine phosphatase activity; protein-tyrosine-phosphatase activity; tyrosine O-phosphate phosphatase activity |
| Major function | Catalysis of the removal of a phosphate group from a protein tyrosine residue |
| Reaction | protein tyrosine phosphate + H2O = protein tyrosine + phosphate |
| Enzyme class | Hydrolase (EC 3.1.3.48) |
| Representative genes | PTPN11, PTPRA, PTPN12, PTPN1, PTPN6, PTPRC, PTPRJ, PTPN2, PTPN3, PTPN4, PTPN9, PTPN13, PTPN14, PTPN22, PTPN23, PTP4A1, PTP4A2, PTP4A3, DUSP1, DUSP3, CDC25A, CDC25B, CDC25C, ACP1, PTPMT1, EYA1, EYA2, EYA3, EYA4 |
| Cellular context | Cytoplasm, plasma membrane, nucleus, and receptor-associated complexes |
What Is GO:0004725?
GO:0004725 protein tyrosine phosphatase activity is defined as the catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate. In other words, it is the enzymatic removal of a phosphate group from a phosphorylated tyrosine residue on a protein substrate, releasing free phosphate and regenerating the unphosphorylated tyrosine.
Why Is protein tyrosine phosphatase activity Important in Cell Biology?
Protein tyrosine phosphatase activity is essential for maintaining the dynamic balance of tyrosine phosphorylation that governs nearly every aspect of cell physiology, from growth factor signaling to immune responses. Because PTPs act as negative regulators or modulators of kinase-driven pathways, their dysfunction can lead to uncontrolled proliferation, metabolic dysregulation, or impaired host defense. Understanding GO:0004725 is therefore central to both basic signal transduction research and the development of targeted therapies for cancer, diabetes, and inflammatory diseases.
• PTPs counterbalance protein tyrosine kinases, preventing excessive or prolonged signaling.
• They regulate immune cell activation, including T cell receptor signaling and thymocyte development.
• PTP activity controls metabolic pathways such as leptin receptor signaling and body weight regulation.
• PTP-PEST (PTPN12) mediates hypoxia-induced autophagy and angiogenesis via AMPK activation.
• Plant PTPs such as StPTP1a negatively regulate immunity, showing evolutionary conservation.
• Dysregulated PTP activity is implicated in cancer, diabetes, and autoimmune disorders.
• PTPs are attractive drug targets, driving development of selective inhibitors.
• Fluorogenic sensors enable real-time monitoring of PTP activity in cells and lysates.
• CRISPR models allow precise dissection of PTP gene function in disease contexts.
• PTPs modulate receptor tyrosine kinase signaling, including EphA4 and leptin receptor pathways.
What Happens During protein tyrosine phosphatase activity?
Substrate recognition and binding
In simple terms: The enzyme finds and grabs onto a target protein that has a phosphate tag on a tyrosine residue.
Protein tyrosine phosphatases recognize specific phosphotyrosine-containing substrates through their catalytic domains and, in many cases, through additional targeting or regulatory domains. For example, SHP-2 (PTPN11) contains SH2 domains that bind phosphotyrosine motifs, directing the enzyme to specific signaling complexes. The receptor-like PTP PTPRA localizes to lipid rafts where it regulates Fyn activity and Cbp/PAG phosphorylation in thymocytes. Substrate specificity is determined by the catalytic pocket geometry and by non-catalytic domains that scaffold interactions with partner proteins.
Catalytic hydrolysis of the phosphotyrosine bond
In simple terms: The enzyme uses water to cut the phosphate group off the tyrosine, releasing free phosphate.
The catalytic mechanism involves a conserved cysteine residue in the active site (the CX5R motif) that performs a nucleophilic attack on the phosphate group, forming a covalent thiol-phosphate intermediate. A conserved aspartate residue acts as a general acid/base to facilitate hydrolysis, and water then hydrolyzes the intermediate to release inorganic phosphate and regenerate the free enzyme. This two-step process is highly efficient and specific for phosphotyrosine, distinguishing PTPs from serine/threonine phosphatases.
Conformational changes and regulation
In simple terms: The enzyme can switch between active and inactive shapes, often controlled by other molecules or modifications.
Many PTPs are regulated by reversible oxidation of the catalytic cysteine, which inactivates the enzyme under oxidative stress conditions. Others are controlled by phosphorylation, SUMOylation, or binding of regulatory partners. For instance, PTP-PEST is activated downstream of hypoxia and AMPK signaling to promote autophagy and angiogenesis. In plants, StPTP1a is activated by the MAP kinase StMKK1 to negatively regulate immunity, illustrating conserved regulatory logic.
Downstream signaling consequences
In simple terms: Removing the phosphate tag changes the behavior of the target protein and the signals it sends.
Dephosphorylation of tyrosine residues can activate or inhibit downstream pathways depending on the substrate. For example, PTPRA inhibits hypothalamic leptin receptor signaling, thereby regulating body weight in vivo. In osteoclasts, a miR17/PTP-oc/EphA4 regulatory axis controls osteoclast activity, showing how PTPs integrate into complex regulatory networks. In endothelial cells, PTP-PEST-mediated AMPK activation drives autophagy and angiogenesis under hypoxia.
Key Genes Involved in GO:0004725 protein tyrosine phosphatase activity
The following genes encode proteins that possess or directly regulate protein tyrosine phosphatase activity (GO:0004725), as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTPN11 | Encodes SHP-2, a non-receptor PTP with SH2 domains that regulates RTK signaling | Mutations cause Noonan syndrome and leukemias; key model for signaling studies |
| PTPRA | Receptor-like PTP that regulates Fyn and leptin receptor signaling | Implicated in thymocyte development and body weight control |
| PTPN12 | Encodes PTP-PEST, a non-receptor PTP regulating autophagy and angiogenesis | Mediates hypoxia-induced AMPK activation in endothelial cells |
| PTPN1 | Encodes PTP1B, a major negative regulator of insulin and leptin signaling | Target for diabetes and obesity research |
| PTPN6 | Encodes SHP-1, a hematopoietic PTP that dampens immune signaling | Studied in autoimmune and inflammatory models |
| PTPRC | Encodes CD45, a receptor PTP essential for T and B cell activation | Critical for immune cell signaling studies |
| PTPRJ | Encodes DEP-1, a receptor PTP that suppresses growth factor signaling | Candidate tumor suppressor in cancer research |
| PTPN2 | Non-receptor PTP regulating cytokine signaling and immune homeostasis | Linked to autoimmunity and cancer |
| PTPN22 | Lymphoid-specific PTP that attenuates T cell receptor signaling | Associated with autoimmune diseases |
| PTP4A3 | Encodes PRL-3, a prenylated PTP promoting cell migration and metastasis | Oncology target for metastasis research |
| DUSP1 | Dual-specificity phosphatase that can act on phosphotyrosine | Regulates MAP kinase pathways |
| CDC25A | Dual-specificity phosphatase controlling cell cycle progression | Studied in cancer and cell cycle checkpoints |
| ACP1 | Low molecular weight PTP involved in cellular metabolism | Model for small PTP structure-function studies |
| EYA1 | Protein tyrosine phosphatase with transactivation activity | Implicated in developmental disorders |
| PTPMT1 | Mitochondrial PTP regulating lipid metabolism | Target for metabolic disease research |
| PTPN3 | Non-receptor PTP with FERM domain, regulates cytoskeletal signaling | Studied in cancer and cell adhesion |
| PTPN13 | Large non-receptor PTP involved in apoptosis and tumor suppression | Relevant to cancer biology |
| PTPN14 | Non-receptor PTP regulating cell junction and Hippo signaling | Model for epithelial polarity studies |
How Is protein tyrosine phosphatase activity Regulated?
Protein tyrosine phosphatase activity is regulated at multiple levels. Reversible oxidation of the catalytic cysteine can transiently inactivate PTPs during cellular oxidative bursts. Phosphorylation and SUMOylation of PTPs modulate their activity and interactions. In plants, StPTP1a is activated by the MAP kinase StMKK1 to negatively regulate immunity, demonstrating kinase-mediated control of PTP function. Additionally, PTP-PEST is activated downstream of hypoxia and AMPK signaling, linking metabolic stress to PTP activity. These regulatory mechanisms ensure that PTPs are switched on and off in coordination with upstream signals.
protein tyrosine phosphatase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTPN11 | Noonan syndrome, leukemia | Knock-in of patient mutations in cell lines; KO in hematopoietic models |
| PTPRA | Obesity, leptin resistance | Hypothalamic neuron-specific KO; point mutation of catalytic cysteine |
| PTPN12 | Angiogenesis, hypoxia response | Endothelial cell KO; overexpression of catalytically dead mutant |
| PTPN22 | Autoimmune diseases | T cell-specific KO; knock-in of risk allele |
| PTP4A3 | Cancer metastasis | Overexpression in cancer cell lines; KO in metastasis models |
Cancer and metastasis
Dysregulated protein tyrosine phosphatase activity contributes to cancer through loss of tumor suppressor PTPs or gain of oncogenic PTPs. For example, PTPRJ (DEP-1) acts as a tumor suppressor, while PTP4A3 (PRL-3) promotes metastasis. SHP-2 (PTPN11) mutations are found in leukemias and solid tumors, driving hyperactive RAS-MAPK signaling. Targeting PTPs with selective inhibitors is an active area of drug discovery.
Metabolic and cardiovascular disorders
PTPs regulate insulin and leptin signaling, and their dysfunction is linked to obesity and diabetes. PTPRA inhibits hypothalamic leptin receptor signaling and regulates body weight in vivo. PTP-PEST mediates hypoxia-induced autophagy and angiogenesis via AMPK activation, implicating it in cardiovascular and ischemic responses. These findings position PTPs as potential therapeutic targets for metabolic and vascular diseases.
Immune and inflammatory diseases
PTPs are critical for immune cell signaling. PTPRA regulates Fyn activity and Cbp/PAG phosphorylation in thymocyte lipid rafts, influencing T cell development. PTPN22 attenuates T cell receptor signaling and is associated with autoimmune diseases. Plant PTP StPTP1a negatively regulates immunity, highlighting the evolutionary importance of PTPs in host defense.
From protein tyrosine phosphatase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PTPN11 affect hematopoietic differentiation? | CRISPR knockout in primary hematopoietic stem cells or cell lines |
| How does PTPRA catalytic activity regulate leptin signaling? | Point mutation (Cys to Ser) knock-in in hypothalamic cell lines |
| Can PTP-PEST-mediated AMPK activation be monitored in live cells? | Knock-in of fluorescent tags or fluorogenic sensors |
| What is the effect of PTPN22 risk allele on T cell signaling? | Knock-in of the R620W variant in Jurkat or primary T cells |
| Does overexpression of PTP4A3 promote metastasis? | Overexpression in cancer cell lines followed by xenograft assays |
| How does StPTP1a regulate plant immunity? | Knockout and overexpression in plant models |
How to Study the protein tyrosine phosphatase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorogenic phosphatase assay | Real-time dephosphorylation of phosphotyrosine substrates | High-throughput screening of PTP inhibitors |
| Phospho-specific immunoblotting | Levels of phosphorylated tyrosine on target proteins | Validation of PTP substrate specificity |
| Structure-based virtual screening | Binding affinity of small molecules to PTP active site | Discovery of selective PTP inhibitors |
| CRISPR knockout | Loss-of-function phenotype for a PTP gene | Functional studies in cell lines and primary cells |
| Knock-in of point mutations | Effect of catalytic or regulatory mutations | Dissecting PTP domain functions |
| Overexpression | Gain-of-function effects of a PTP | Cancer and signaling studies |
| In vivo metabolic phenotyping | Body weight, leptin sensitivity | Studying PTPRA in energy balance |
| Lipid raft isolation | Localization of PTPs and substrates in membrane microdomains | Thymocyte signaling research |
Fluorogenic sensors for real-time PTP activity
Multipartite fluorogenic sensors enable sensitive detection of tyrosine phosphatase activity in vitro and in live cells, allowing researchers to monitor enzyme kinetics and inhibition in real time. These sensors typically consist of a phosphotyrosine-containing peptide linked to a fluorophore and quencher, which releases fluorescence upon dephosphorylation.
Structure-based virtual screening for PTP inhibitors
Computational docking and virtual screening against the catalytic domains of PTPs have identified small-molecule inhibitors with potential therapeutic value. This approach leverages the conserved active site architecture while aiming for selectivity among PTP family members.
Genetic and biochemical assays for PTP function
Knockout, knockdown, and overexpression studies combined with phospho-specific immunoblotting allow researchers to map PTP substrate specificity and downstream effects. For example, PTPRA regulation of Fyn and Cbp/PAG phosphorylation was demonstrated using thymocyte lipid raft preparations. Similarly, PTP-PEST-mediated AMPK activation was shown by phospho-AMPK immunoblotting under hypoxia.
In vivo models for PTP-related physiology
Animal models, including conditional knockouts and transgenic overexpression, are used to study PTP roles in body weight regulation, immune function, and angiogenesis. PTPRA knockout mice display altered leptin sensitivity and body weight, demonstrating the physiological importance of this PTP.
How CRISPR Can Be Used to Study GO:0004725 protein tyrosine phosphatase activity
Knockout
CRISPR knockout of PTP genes is widely used to eliminate enzyme activity and assess loss-of-function phenotypes. For example, knocking out PTPN12 (PTP-PEST) in endothelial cells can reveal its role in hypoxia-induced autophagy and angiogenesis. Similarly, PTPN11 knockout in hematopoietic cells helps define SHP-2 function in signaling.
Point Mutation
Point mutations in the catalytic cysteine (Cys to Ser) or in regulatory domains can abolish or alter PTP activity without affecting protein expression. This approach is valuable for separating catalytic activity from scaffolding functions, as demonstrated for PTPRA in leptin receptor signaling.
Knock-in
Knock-in of disease-associated variants, such as PTPN22 R620W, allows researchers to study how specific mutations affect PTP function in a physiological context. Knock-in of fluorescent tags or biosensors can also enable real-time monitoring of PTP activity in live cells.
Overexpression
CRISPR activation or traditional overexpression of PTPs such as PTP4A3 can drive gain-of-function phenotypes, including enhanced cell migration and metastasis. Overexpression of plant PTP StPTP1a was used to demonstrate its negative regulation of immunity.
How EDITGENE Supports protein tyrosine phosphatase activity Research
Researchers studying protein tyrosine phosphatase activity-related genes often need to determine whether a candidate gene is causally involved in a specific signaling pathway or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this functional validation, from generating precise knockout lines to engineering disease-relevant point mutations and knock-in reporters.
Contact EDITGENE today to design your custom CRISPR model for protein tyrosine phosphatase activity research.
Frequently Asked Questions About protein tyrosine phosphatase activity
What is protein tyrosine phosphatase activity?
Protein tyrosine phosphatase activity (GO:0004725) is the enzymatic removal of a phosphate group from a phosphorylated tyrosine residue on a protein, releasing free phosphate and regenerating the unphosphorylated tyrosine.
What genes are involved in protein tyrosine phosphatase activity?
Genes encoding PTPs include PTPN11 (SHP-2), PTPRA, PTPN12 (PTP-PEST), PTPN1 (PTP1B), PTPN6 (SHP-1), PTPRC (CD45), PTPRJ, PTPN22, PTP4A3, and many others.
How is protein tyrosine phosphatase activity measured?
It can be measured using fluorogenic sensors that detect phosphate release in real time, or by phospho-specific immunoblotting of substrate proteins.
What diseases are associated with protein tyrosine phosphatase activity?
Dysregulated PTP activity is linked to cancer, metabolic disorders such as obesity and diabetes, and autoimmune diseases.
What is the difference between protein tyrosine phosphatases and kinases?
PTPs remove phosphate groups from tyrosine residues, while kinases add them; together they control the reversible phosphorylation that regulates signaling.
Can protein tyrosine phosphatases be drug targets?
Yes, PTPs are considered attractive drug targets, and structure-based virtual screening has identified small-molecule inhibitors for several PTPs.
How do CRISPR knockouts help study protein tyrosine phosphatases?
CRISPR knockout eliminates the enzyme, allowing researchers to observe loss-of-function phenotypes and identify the pathways controlled by that PTP.
What is the role of PTP-PEST in angiogenesis?
PTP-PEST (PTPN12) mediates hypoxia-induced endothelial autophagy and angiogenesis via AMPK activation.
How does PTPRA regulate body weight?
PTPRA inhibits hypothalamic leptin receptor signaling, and its loss leads to altered leptin sensitivity and body weight regulation in vivo.
What are the synonyms for protein tyrosine phosphatase activity?
Common synonyms include PTPase activity, phosphotyrosine phosphatase activity, protein-tyrosine-phosphatase activity, and tyrosine O-phosphate phosphatase activity.
Conclusion
Protein tyrosine phosphatase activity (GO:0004725) is a central enzymatic function that counterbalances tyrosine kinase signaling and controls diverse physiological processes, from immune responses to metabolism and angiogenesis. Its dysregulation contributes to cancer, metabolic disorders, and autoimmune diseases, making PTPs important research and therapeutic targets. Advances in fluorogenic sensors, structural screening, and CRISPR-based models are accelerating our understanding of PTP biology and enabling the development of selective modulators.
References
- 1. Lau KW et al.. 2018. A novel miR17/protein tyrosine phosphatase-oc/EphA4 regulatory axis of osteoclast activity.. Arch Biochem Biophys 650:30-38 PMID: 29763590
- 2. Hansen DT et al.. 2024. Multipartite Fluorogenic Sensors for Monitoring Tyrosine Phosphatase Activity.. Chembiochem 25(24):e202400607 PMID: 39406683
- 3. Li F et al.. 2023. Potato protein tyrosine phosphatase StPTP1a is activated by StMKK1 to negatively regulate plant immunity.. Plant Biotechnol J 21(3):646-661 PMID: 36519513
- 4. Stein-Gerlach M et al.. 1998. SHP-2, SH2-containing protein tyrosine phosphatase-2.. Int J Biochem Cell Biol 30(5):559-66 PMID: 9693956
- 5. Reddy RH et al.. 2017. Structure-Based Virtual Screening of Protein Tyrosine Phosphatase Inhibitors: Significance, Challenges, and Solutions.. J Microbiol Biotechnol 27(5):878-895 PMID: 28238001
- 6. Maksumova L et al.. 2005. Protein tyrosine phosphatase alpha regulates Fyn activity and Cbp/PAG phosphorylation in thymocyte lipid rafts.. J Immunol 175(12):7947-56 PMID: 16339530
- 7. Chandel S et al.. 2021. The protein tyrosine phosphatase PTP-PEST mediates hypoxia-induced endothelial autophagy and angiogenesis via AMPK activation.. J Cell Sci 134(1) PMID: 33323505
- 8. Cohen-Sharir Y et al.. 2019. Protein tyrosine phosphatase alpha inhibits hypothalamic leptin receptor signaling and regulates body weight in vivo.. FASEB J 33(4):5101-5111 PMID: 30615487
